Showing results (1831-1840 of 1,899) with videos related to

Sort By:
Pageof 190
Asian Journal of Andrology|January 10, 2025
Novel biallelic MCMDC2 variants were associated with meiotic arrest and nonobstructive azoospermiaHao-Wei Bai, Na Li, Yu-Xiang Zhang, et al.
Cell Systems|March 12, 2018
The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer ChronotherapyYouqiong Ye, Yu Xiang, Fatma Muge Ozguc, et al.
Journal of Molecular Cell Biology|July 21, 2016
Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissueHu Xu, Jia-Lin Fu, Yi-Fei Miao, et al.
BMC Medicine|January 4, 2023
Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies-pharmacovigilance database analysis with real-world data validationXue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, et al.
International Journal of Cancer|February 18, 2011
Expression of CD147 is associated with prostate cancer progressionWei-de Zhong, Yu-Xiang Liang, Sharron X Lin, et al.
Chinese Journal of Integrative Medicine|June 20, 2023
Yinlai Decoction Protects Microstructure of Colon and Regulates Serum Level of D-Lactic Acid in Pneumonia Mice Fed with High-Calorie and High-Protein DietYun-Hui Wang, He Yu, Tie-Gang Liu, et al.
Frontiers in Molecular Biosciences|February 15, 2021
Baicalin Induces Apoptosis and Suppresses the Cell Cycle Progression of Lung Cancer Cells Through Downregulating Akt/mTOR Signaling PathwayXinbing Sui, Xuemeng Han, Peng Chen, et al.
Cellular Immunology|October 9, 2016
BTLA-expressing CD11c antigen presenting cells in patients with active tuberculosis exhibit low capacity to stimulate T cell proliferationWan-Dang Wang, Yu-Chi Gao, Yuan-Bin Lu, et al.
Future Oncology (London, England)|December 23, 2014
Phase I dose-escalation study of aflibercept plus docetaxel in nasopharyngeal carcinoma and other solid tumorsYan Huang, Ben-Yan Zou, Li-Ping Zhao, et al.
Cancer Letters|July 14, 2018
Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancerXue-Ling Liu, Yi-Chao Xu, Yu-Xiang Wang, et al.
Pageof 190